Insulin Delivery Devices Market: Current Analysis and Forecast (2021-2027)

$3999$7577

Emphasis on Type [Insulin Pens (Reusable, Disposable), Insulin Pumps (External, Tethered, Patch), Insulin Syringes, Insulin Jet Injectors, Other Devices]; End-User (Patients/Homecare, Hospitals & Clinics); Region/Country

Published:

Feb-2022

Pages:

227

Table:

49

Figure:

124

Report ID:

UMHE21665

Geography:

Clear
  Get a Free Sample
SKU: UMHE21665 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Insulin Delivery Devices Market 2
Insulin Delivery Devices Market 2

Insulin Delivery Devices Market is expected to grow at a CAGR of around 10% over the forecast period (2021-2027). The rise of this market is fueled by a growing diabetic population, obesity, and a sedentary lifestyle. Furthermore, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, as well as rising awareness among the population about diabetes control and accessibility to insulin delivery systems, are all factors ensuring the market’s growth.

Several government organizations are focusing on boosting the existing infrastructure for overall healthcare system development. Among the countries worldwide, the United States had the highest percentage of gross domestic product spent on health care in 2019. The U.S. spent nearly 17% of its GDP on health care services. Germany, Switzerland, and France followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries.

The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.

Worldwide Prevalence of Overweight in Adults, (%), By Country

Insulin Delivery Devices Market 3
Insulin Delivery Devices Market 3

Some of the major players operating in the market include Medtronic, Becton, Dickinson and Company, Novo Nordisk, Eli Lilly and Company, Sanofi, Insulet Corporation, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Animas Corporation, Biocon Ltd, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.

Insights Presented in the Report

“Amongst Type, Insulin Pens segment dominated the market in 2020”

Based on Type, the market is segmented into Insulin Pens (Reusable, Disposable), Insulin Pumps (External, Tethered, Patch), Insulin Syringes, Insulin Jet Injectors and Other Devices. The Insulin Pens segment leads the Insulin Delivery Devices Market. Insulin pens are growing in popularity, and many people with diabetes nowadays use a pen to administer insulin as it allows more simple, accurate, and convenient delivery than using a vial and syringe.

“Amongst End-User, Patients/Homecare segment dominated the market in 2020.”

Based on End-User, the Insulin Delivery Devices market is segmented into Patients/Homecare and Hospitals & Clinics. The patients/homecare segment commanded the largest share of the insulin delivery devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.

“North America represents as the largest market.”

For a better understanding of the market adoption of Insulin Delivery Devices, the market is analyzed for the countries such as North America (US, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), & Rest of World. Asia-Pacific dominated the market in 2020. North America dominated the market. The rising prevalence of diabetes and favorable reimbursement scenario in the United States and Canada, growing venture capital investments and IPOs in the United States, and FDA approvals to increase the commercial availability of insulin delivery devices in the United States all contribute to this region’s large share.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional & country-level analysis of the industry

Customization Options:

Insulin Delivery Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Limitation
1.3.Stake Holders
1.4.Currency used in Report

 

2.1.Research Process of the Insulin Delivery Devices Market
2.2.Research Methodology of the Insulin Delivery Devices Market
2.3.Forecasting Method
2.4.Respondent Profile
2.5.Main Objective of the Insulin Delivery Devices Market Study

 

3MARKET SYNOPSIS

 

4EXECUTIVE SUMMARY

 

5INSULIN DELIVERY DEVICES MARKET COVID-19 IMPACT

 

6INSULIN DELIVERY DEVICES MARKET REVENUE, 2019-2027F

 

7.1.Insulin Pens
 7.1.1.Reusable
 7.1.2. Disposable
7.2.Insulin Pumps
 7.2.1. External
 7.2.2. Tethered
 7.2.3. Patch
7.3.Insulin Syringes
7.4.Insulin Jet Injectors
7.5.Other Devices

 

8.1.Patients/Homecare
8.2.Hospitals & Clinics

 

9.1.NORTH AMERICA INSULIN DELIVERY DEVICES MARKET 
 9.1.1.United States
 9.1.2.Canada
 9.1.3.Rest of North America
9.2.EUROPE INSULIN DELIVERY DEVICES MARKET 
 9.2.1.Germany
 9.2.2.France
 9.2.3.United Kingdom
 9.2.4.Italy
 9.2.5.Spain
 9.2.6.Rest of Europe
9.3.ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET 
 9.3.1.China
 9.3.2.Japan
 9.3.3.India
 9.3.4.Australia
 9.3.5.Rest of Asia Pacific
9.4.REST OF WORLD INSULIN DELIVERY DEVICES MARKET 

 

10.1.Market Drivers
10.2.Market Challenges
10.3.Impact Analysis

 

11INSULIN DELIVERY DEVICES MARKET OPPORTUNITIES

 

12INSULIN DELIVERY DEVICES MARKET TRENDS

 

13INSULIN DELIVERY DEVICES & REGULATORY FRAMEWORK 

 

14.1.Demand Side Analysis
14.2.Supply Side Analysis

 

15VALUE CHAIN ANALYSIS

 

16.1.COMPETITIVE LANDSCAPE
 16.1.1.Company Shares, By Revenue

 

17.1.Medtronic
17.2.Becton, Dickinson and Company
17.3.Novo Nordisk
17.4.Eli Lilly and Company
17.5.Sanofi
17.6.Insulet Corporation
17.7.Ypsomed Holding AG
17.8.Tandem Diabetes Care, Inc.
17.9.Animas Corporation
17.10.Biocon Ltd.

 

18DISCLAIMER

 

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future of the Insulin Delivery Devices Market were the three major steps undertaken to create and analyze the adoption of Insulin Delivery Devices across various regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted, with industry experts across the value chain of the industry. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below.

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of Insulin Delivery Devices through company internal sources such as annual report & financial statements, investor presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Insulin Delivery Devices, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are by type and end-user. Further regional & country-level analyses were conducted to evaluate the overall adoption of the Insulin Delivery Devices Market in the global context.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size. Further, we conducted factor analysis using dependent and independent variables such as technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices, etc. Historical trends and their year-on-year impact on the market size and share was analyzed. Demand and supply side scenario was also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Market, and market shares of the segments and company. All the required percentage split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast to 2027 for different segments and subsegments across the major regions globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$)
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Insulin Delivery Devices Market in terms of products & services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major countries. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Insulin Delivery Devices Market 1
Insulin Delivery Devices Market 1

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of Insulin Delivery Devices Market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of power source, class, and application for the major country/region globally.

The main objective of the Insulin Delivery Devices Market Study

The current & future market trends of Insulin Delivery Devices were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional & country level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Insulin Delivery Devices in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include Type and End-User
  • Analyze the current and forecast market size of the Insulin Delivery Devices for the major regions & countries
  • Major regions studied in the report include North America (United States, Canada, Rest of North America), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia Pacific (China, Japan, India, Australia, Rest of Asia- Pacific), and Rest of World
  • Company profiles of the Insulin Delivery Devices Market players and the growth strategies adopted by them to sustain in the fast-growing market
  • Deep dive regional & country level analysis of the industry